1. Home
  2. PRAX vs CAG Comparison

PRAX vs CAG Comparison

Compare PRAX & CAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$282.31

Market Cap

7.1B

Sector

Health Care

ML Signal

HOLD

Logo ConAgra Brands Inc.

CAG

ConAgra Brands Inc.

HOLD

Current Price

$13.20

Market Cap

6.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRAX
CAG
Founded
2015
1919
Country
United States
United States
Employees
N/A
26100
Industry
Biotechnology: Pharmaceutical Preparations
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
6.4B
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
PRAX
CAG
Price
$282.31
$13.20
Analyst Decision
Strong Buy
Hold
Analyst Count
15
17
Target Price
$572.13
$16.88
AVG Volume (30 Days)
475.2K
14.4M
Earning Date
05-08-2026
04-01-2026
Dividend Yield
N/A
9.84%
EPS Growth
N/A
233.33
EPS
N/A
N/A
Revenue
N/A
$1,500,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$7,758.26
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$37.25
$12.53
52 Week High
$366.52
$21.78

Technical Indicators

Market Signals
Indicator
PRAX
CAG
Relative Strength Index (RSI) 47.14 43.64
Support Level $238.77 $12.53
Resistance Level $342.62 $14.56
Average True Range (ATR) 21.47 0.42
MACD 0.62 0.07
Stochastic Oscillator 39.34 43.93

Price Performance

Historical Comparison
PRAX
CAG

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About CAG ConAgra Brands Inc.

Conagra Brands is a packaged food company that operates predominantly in the United States (91% of fiscal 2025 revenue). Most of its revenue comes from frozen food, including brands like Marie Callender's, Healthy Choice, Banquet, and Birds Eye. Conagra also sells snacks, shelf-stable staples, and refrigerated food through brands like Duncan Hines, Hunt's, Slim Jim, Vlasic, Orville Redenbacher's, Reddi-wip, and Wish-Bone. The company primarily sells through the US retail channel, with just 9% of fiscal 2025 revenue coming from international markets and 9% from foodservice.

Share on Social Networks: